BREAKING THROUGH DEFENSES, DELIVERING HOPE
Abstract
Stem cells for medical purposes; Drug delivery systems, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the treatment of rare diseases tumors, cancer, auto-immune, and inflammatory diseases; stem cell delivery agent in the form of micro-beads for use in stem cell delivery for patients; regenerative medicinal products, namely, cell, cellular component, and stem cell processing and application medical devices for medical application being cell growth media for growing cells for use medical use; Drug delivery systems, namely, implantable subcutaneous drug delivery device in the nature of drug delivery ports; drug delivery systems primarily comprised of drug delivery catheters and medical micro-robots for delivering stem cells into a targeted area in humans; stem cell delivery apparatus for medical use, namely, implantable stem cell delivery ports, medical mic-robots for stem cell delivery; medical biohybrid, synthetic and hybrid micro-robots for use in stem cell delivery for patients; apparatus for the regeneration of stem cells for medical purposes; regenerative medicinal products, namely, cell, cellular component, and stem cell processing and application medical devices for medical application being cell regeneration apparatus; regenerative medicinal products, namely, cell, cellular component, and stem cell extraction medical devices for medical application being needles for medical purposes; medical apparatuses for implementing treatment methods using stem cells; Stem cell therapy services; Providing information in the field of stem-cell therapies and stem-cell therapies related to tumors, cancer, auto-immune and inflammatory diseases; stem call bank services; medical services relating to the removal, treatment and processing of stem cells; Research and development in the field of stem-cell therapies; Research and development in the field of stem-cell therapies for treatment of tumors, cancer, auto-immune, and inflammatory diseases; research and development in the field of stem-cell therapies, namely, synthetic induced mesenchymal stem-cell therapies (iMSC); Stem cell research services; Stem cells for research or scientific purposes; stems cells for medical research
Filing Date
2025-03-28